Biologics
- Modalities
  
  Mammalian
  
  Microbial
  
  ADCs / Bioconjugates
  
  mRNA / LNP
  
  Drug Product
- Technologies & Products
  
  Expression Technologies
  
  Discovery Products
  
  Bioprocessing Products
- Discovery and Preclinical
  
  Early De-risking & Optimization
  
  Cell Line & Strain Development
  
  Process Development & Optimization
  
  Analytical Development
  
  Formulation Development
  
  Non-GMP Manufacture
- Clinical and Commercial
  
  Process Development & Optimization
  
  Formulation Optimization
  
  cGMP Drug Substance Manufacture
  
  cGMP Drug Product Manufacture
Technical Support

Regulatory Support

View all locations

View all Biologics offerings

Knowledge Center

View all the latest resources available on site

Visit our Knowledge Center
Small Molecules
- Services
  
  Drug Substance (API)
  
  Particle Engineering
  
  Drug Product
- Technologies
  
  Highly Potent API (HPAPI)
  
  ADCs
  
  Spray Dried Dispersions
  
  Micronization & Jet Milling
  
  Inhaled Delivery (DPI)
- Solutions
  
  Early Phase API
  
  Commercial Production API
  
  Bioavailability Enhancement
  
  Integrated Offerings
- Knowledge Center
  
  Webinars
  
  Presentations
  
  Publications
  
  Meet the Experts
  
  View all
View all Small Molecules offerings

View all locations

Knowledge Center

View all the latest resources

Visit our Knowledge Center
Cell & Gene
- Services
  
  Process Development
  
  cGMP Manufacturing
  
  Regulatory Consulting
  
  Bioassay Services
  
  Tissue Acquisition
- Modalities
  
  Autologous
  
  Allogeneic
  
  Viral Vectors
  
  iPSCs
  
  Exosomes
- Technologies
  
  MODA® Platform
  
  Cocoon® Platform
  
  Nucleofector® Technology
  
  TheraPEAK® Media
  
  Endotoxin and Pyrogen Testing
- Knowledge Center
  
  Peer-reviewed publications
  
  Webinars
  
  R&D Blog post
  
  Whitepapers/Executive Summary
  
  Poster
  
  View all
View all Cell & Gene offerings

View all Bioscience Products

View all locations
Capsules & Health Ingredients
- Pharmaceutical Solutions
- Nutraceutical Solutions
Contact

Biologics

Modalities

Mammalian
Microbial
ADCs / Bioconjugates
mRNA / LNP
Drug Product

Technologies & Products

Expression Technologies
Discovery Products
Bioprocessing Products

Discovery and Preclinical

Early De-risking & Optimization
Cell Line & Strain Development
Process Development & Optimization
Analytical Development
Formulation Development
Non-GMP Manufacture

Clinical and Commercial

Process Development & Optimization
Formulation Optimization
cGMP Drug Substance Manufacture
cGMP Drug Product Manufacture

Back

Small Molecules

Small Molecules

Services

Drug Substance (API)
Particle Engineering
Drug Product

Technologies

Highly Potent API (HPAPI)
ADCs
Spray Dried Dispersions
Micronization & Jet Milling
Inhaled Delivery (DPI)

Solutions

Early Phase API
Commercial Production API
Bioavailability Enhancement
Integrated Offerings

Knowledge Center

Webinars
Presentations
Publications
Meet the Experts
View all

Back

Cell & Gene

Services

Process Development
cGMP Manufacturing
Regulatory Consulting
Bioassay Services
Tissue Acquisition

Modalities

Autologous
Allogeneic
Viral Vectors
iPSCs
Exosomes

Technologies

MODA® Platform
Cocoon® Platform
Nucleofector® Technology
TheraPEAK® Media
Endotoxin and Pyrogen Testing

Knowledge Center

Peer-reviewed publications
Webinars
R&D Blog post
Whitepapers/Executive Summary
Poster
View all

Back

Capsules & Health Ingredients

Capsules & Health Ingredients

Pharmaceutical Solutions

Nutraceutical Solutions

Back

Back

Home
Knowledge Center
Meet the Experts

Meet the Experts

This community is composed of technical experts who have decades of experience in topics ranging from drug substance manufacture and solid form selection to drug product at feasibility to commercial scales. Each of our Subject Matter Experts have extensive experience in one or more of the following areas: Drug Substance/API, Bioavailability Enhancement, First-in-Human, Solid Form Selection, Dosage Forms/Multiparticulates, Inhalation, Mammalian Expression Systems, and Microbial Expression Systems.

Filter by Area of Expertise

Bioavailability Enhancement Bioconjugates/ADC Drug Substance/HPAPI Early De-Risking and Optimization First-in-Human Ibex® Dedicate IND-to-BLA Inhalation Mammalian Expression Systems Microbial Expression Systems Molecular Biology mRNA/LNP Multiparticulates Parenteral Drug Product PBPK Modeling Small Molecules - Commercial Solid Form Selection

Filter by Offering

Small Molecules (34) Biologics (25)

Abhijeet Sinha, Ph.D.

Abhijeet Sinha, Ph.D.

Solid Form Selection

Explore expertise

Alice Harrison

Mammalian Expression Systems

Explore expertise

Andreas Sieber, Ph.D.

Andreas Sieber, Ph.D.

Solid Form Selection

Explore expertise

Andrew Brown

Mammalian Expression Systems

Explore expertise

Antoine Klaue

Drug Substance/HPAPI

Explore expertise

Arundhati Chattopadhyay, Ph.D.

Arundhati Chattopadhyay, Ph.D.

Parenteral Drug Product

Explore expertise

Beatriz Fernandes

Beatriz Fernandes

Bioavailability Enhancement

Explore expertise

Bernhard Gutmann, Ph.D.

Bernhard Gutmann, Ph.D.

Drug Substance/HPAPI

Explore expertise

Bernhard Stump, Ph.D.

Bernhard Stump, Ph.D.

Bioconjugates/ADC | IND-to-BLA

Explore expertise

Brian Schwegler

Brian Schwegler

Drug Substance/HPAPI

Explore expertise

Cameron Kadleck

Cameron Kadleck

Inhalation

Explore expertise

Carmen Juds, Ph.D.

Carmen Juds, Ph.D.

Bioconjugates/ADC

Explore expertise

Charles Johnson

Charles Johnson

Drug Substance/HPAPI

Explore expertise

Christian Noti, Ph.D.

Christian Noti, Ph.D.

Drug Substance/HPAPI

Explore expertise

Christoph Grapentin, Ph.D.

Christoph Grapentin, Ph.D.

Parenteral Drug Product

Explore expertise

Claudia Müller, Ph.D.

Claudia Müller, Ph.D.

Parenteral Drug Product

Explore expertise

Clemens Jakobi

mRNA/LNP

Explore expertise

Cody Prather

Inhalation

Explore expertise

Conrad Roten, Ph.D.

Conrad Roten, Ph.D.

Drug Substance/HPAPI

Explore expertise

David Dreifke

First-in-Human

Explore expertise

David Hall

Small Molecules - Commercial

Explore expertise

David Lyon, Ph.D.

David Lyon, Ph.D.

Bioavailability Enhancement

Explore expertise

Deanna Mudie, Ph.D.

Deanna Mudie, Ph.D.

Bioavailability Enhancement

Explore expertise

Dominique Roberge, Ph.D.

Dominique Roberge, Ph.D.

Drug Substance/HPAPI

Explore expertise

Elisabeth Engelsberger, Ph.D.

Elisabeth Engelsberger, Ph.D.

Bioconjugates/ADC

Explore expertise

Friederike Hermann, Ph.D.

Friederike Hermann, Ph.D.

Drug Substance/HPAPI

Explore expertise

Giovanna Libralon

Giovanna Libralon

Small Molecules - Commercial

Explore expertise

Gordon Bates

Small Molecules - Commercial

Explore expertise

Hannah Sullivan, PE

Hannah Sullivan, PE

Multiparticulates

Explore expertise

Heiko Nalenz, Ph.D.

Heiko Nalenz, Ph.D.

Parenteral Drug Product

Explore expertise

Iwan Bertholjotti

Iwan Bertholjotti

Bioconjugates/ADC | IND-to-BLA | Ibex® Dedicate

Explore expertise

Jakob Bonde

First-in-Human

Explore expertise

Jean-Sebastien Steffen, Ph.D.

Jean-Sebastien Steffen, Ph.D.

Parenteral Drug Product

Explore expertise

Jimmy Rosedale

Inhalation

Explore expertise

Joachim Klein, Ph.D.

Joachim Klein, Ph.D.

Microbial Expression Systems

Explore expertise

Joel Wood

Bioavailability Enhancement

Explore expertise

Josh Marsh

PBPK Modeling

Explore expertise

Kimberly Shepard, Ph.D.

Kimberly Shepard, Ph.D.

Inhalation

Explore expertise

Léa Sorret, Ph.D.

Léa Sorret, Ph.D.

Parenteral Drug Product

Explore expertise

Lisa Prendergast, Ph.D.

Lisa Prendergast, Ph.D.

Molecular Biology

Explore expertise

Logan Howell

Multiparticulates

Explore expertise

Mark Cappucci

First-in-Human

Explore expertise

Matthew Ferguson

Matthew Ferguson

Inhalation

Explore expertise

Maureen Kadleck

Maureen Kadleck

Inhalation

Explore expertise

Maurits Janssen, Ph.D.

Maurits Janssen, Ph.D.

Drug Substance/HPAPI

Explore expertise

Molly Adam

Bioavailability Enhancement

Explore expertise

Monika Geiger, Ph.D.

Monika Geiger, Ph.D.

Parenteral Drug Product

Explore expertise

Niklaus Künzle, Ph.D.

Niklaus Künzle, Ph.D.

Drug Substance/HPAPI

Explore expertise

Nikolay Krumov, Ph.D.

Nikolay Krumov, Ph.D.

Microbial Expression Systems

Explore expertise

Noel Smith, Ph.D.

Noel Smith, Ph.D.

Early De-Risking and Optimization

Explore expertise

Peter O'Callaghan, Ph.D.

Peter O'Callaghan, Ph.D.

Mammalian Expression Systems

Explore expertise

Qifeng Zhang

Mammalian Expression Systems

Explore expertise

Raphael Frey, Ph.D.

Raphael Frey, Ph.D.

Bioconjugates/ADC | Early De-Risking and Optimization

Explore expertise

Raymond Donninger, Ph.D.

Raymond Donninger, Ph.D.

Early De-Risking and Optimization

Explore expertise

Ryan Littich, Ph.D.

Ryan Littich, Ph.D.

First-in-Human

Explore expertise

Salvatore Mercuri, Ph.D.

Salvatore Mercuri, Ph.D.

Bioavailability Enhancement

Explore expertise

Sanghee Yang

Parenteral Drug Product

Explore expertise

Stuart Jamieson

Stuart Jamieson

Mammalian Expression Systems

Explore expertise

Vinay Kamuju

Parenteral Drug Product

Explore expertise

Yvette Stallwood, Ph.D.

Yvette Stallwood, Ph.D.

Early De-Risking and Optimization

Explore expertise

Ways to Contact

Contact Us
Regulatory Support
Locations
Site Tours
Partnering with Us

Resources

Knowledge Center
Meet the Experts
Upcoming Events

Terms & Conditions

Terms and Conditions
Legal Disclaimer
Privacy Policy
California CCPA Notice
Transparency in Coverage

Lonza.com

Company Overview
News & Media
Investor Relations
Sustainability
Careers

© 2023 Lonza. All rights reserved.